"SMS - Heals My Health"

NCT ID: NCT03670108

Last Updated: 2018-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-12

Study Completion Date

2020-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Therapeutic patient education is an approach that has shown its usefulness in rheumatology, but the duration of its impact is limited, and therapeutic revisions are regularly necessary. The practice of physical activity is one of the goals of TPE in rheumatology and new technologies, such as SMS messages represent a possible complementary tool to amplify behavioral changes The study primary objective is to evaluate the impact of individualized SMS compared to standard SMS messages on the physical activity of patients with chronic inflammatory rheumatism or osteoporosis, included in a therapeutic education program. Our hypothesis is that individualized SMS has a higher efficiency compared to standard SMS messages to increase the practice of physical activity in these patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

to Help Improve the Quality of Life of Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients receiving an individualized SMS

No interventions assigned to this group

patients receiving a standard SMS

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient age from 18 to 75 years
* Participated in therapeutic patient education program osteoporosis disease and inflammatory rheumatism disease
* Having given their written consent
* French speaking
* Possessing a telephone tool that accepts SMS

Exclusion Criteria

* Patients unable to read SMS for practical, linguistic or cognitive reasons
* Patients who can not, for medical reasons or disability, set up 30 minutes of moderate physical activity (walking or other moderate activity) per day
* Having already participated in a similar study in inflammatory rheumatism or osteoporosis
* Already having the required level of physical activity: performing more than 30 minutes of moderate physical activity (walking or other moderate activity)
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital Cochin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Serge Perrot

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cochin Hospital

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Terkia MEDKOUR, PHD

Role: CONTACT

0033158411507

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

TERKIA MEDKOUR, PHD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A00580-51

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

My Symptoms - Feasibility Study
NCT05287087 COMPLETED NA
Patient Education and Rheumatoid Arthritis
NCT07170371 ACTIVE_NOT_RECRUITING NA